1337523-99-5

Usage

Uses

Used in Pharmaceutical Synthesis:
6-Bromo-1,2,3,4-tetrahydronaphthalen-1-amine is utilized as a key intermediate in the synthesis of various pharmaceuticals and organic compounds. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Drug Development:
Due to its distinctive chemical properties, 6-Bromo-1,2,3,4-tetrahydronaphthalen-1-amine plays a significant role in drug development. It can be used to create novel molecules with improved pharmacological profiles, enhancing the efficacy and safety of medications.
Used in Medicinal Chemistry:
In the realm of medicinal chemistry, 6-Bromo-1,2,3,4-tetrahydronaphthalen-1-amine serves as a valuable building block for the design and synthesis of bioactive molecules. Its presence in a molecule can modulate its interaction with biological targets, leading to the discovery of new therapeutic agents.
Used as a Research Reagent:
6-Bromo-1,2,3,4-tetrahydronaphthalen-1-amine is also employed as a research reagent in chemical and biological experiments. It aids scientists in understanding the fundamental properties of molecules and their interactions with biological systems, furthering the knowledge base in these fields.

Upstream product

• 228256-58-4 6-bromo-1,2,3,4-tetrahydronaphthalen-1-ol 
• 66361-67-9 6-bromo-3,4-dihydro-2H-naphthalen-1-one 

Relevant academic research and scientific papers

PERIPHERAL ALKYL AND ALKENYL CHAINS EXTENDED BENZENE DERIVATIVES AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME

The compounds represented by Formula (I), which are peripheral alkyl and alkenyl chains extended benzene derivatives, are useful as dual autotaxin (ATX) / histone deacetylase (HD AC) inhibitors. These compounds may be included in a pharmaceutical composition along with a pharmaceutically acceptable carrier, and be used in a therapeutically effective amount for prophylaxis or treatment of various diseases and disorders.

FUSED IMIDAZOPYRIDINES AS REVERSIBLE INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)

The present invention relates to fused imidazo pyridine compounds of formula (I), and pharmaceutically acceptable compositions thereof, useful as BTK inhibitors.

BIARYL COMPOUNDS USEFUL FOR THE TREATMENT OF HUMAN DISEASES IN ONCOLOGY, NEUROLOGY AND IMMUNOLOGY

The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.

NEW ARYL-BENZOCYCLOALKYL AMIDE DERIVATIVES

The invention provides novel compounds having the general formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, A1, A2 and n are as described herein, compositions including the compounds and methods of using the compounds.

NEW ARYL-BENZOCYCLOALKYL AMIDE DERIVATIVES

The invention provides novel compounds having the general Formula (I), wherein R1, R2, R3, R4 R5, R6, R7, R8 R9, R10, R11, R12, A1, A2 and n are as described herein, compositions including the compounds and methods of using the compounds.